GeneralBullishBlockonomi · 4h ago6/10
📰
Merck KGaA Acquires Bio-Techne (TECH) for $11.3 Billion in Major Life Sciences Deal
Merck KGaA announced an $11.3 billion acquisition of Bio-Techne Corporation at $73 per share, representing a 24% premium to previous trading levels. The deal reflects consolidation in the life sciences sector and boosts investor confidence in Bio-Techne's market valuation.